Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
medical source : Ir.viveve.com save search
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
Published: 2023-01-17 (Crawled : 12:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: -68.41%
H: 3.05%
C: -4.31%
topline trial
Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded
Published: 2022-12-15 (Crawled : 14:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 5.25%
H: 6.89%
C: 6.89%
trial
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
Published: 2022-12-01 (Crawled : 14:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 0.0%
H: 2.41%
C: -0.21%
patent
Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-10 (Crawled : 22:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 6.67%
H: 0.0%
C: -10.54%
financial update results
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
Published: 2022-10-27 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -5.25%
report financial update results
Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
Published: 2022-10-04 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 0.0%
H: 4.5%
C: -3.41%
patent
Viveve Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal PURSUIT Trial Readout
Published: 2022-09-27 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 5.22%
H: 1.22%
C: -2.94%
treatment trial readout
Viveve to Participate in Ladenburg Thalmann Healthcare Conference
Published: 2022-09-22 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: -0.25%
H: 1.3%
C: -5.19%
conference
Viveve to Participate in Alliance Global Partners Virtual MedTech Conference
Published: 2022-09-15 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 1.91%
H: 1.67%
C: 0.65%
global conference
Viveve to Participate in H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-01 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 4.94%
H: 0.0%
C: -6.57%
global conference
Viveve Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 20:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: -0.1%
H: 3.07%
C: -2.09%
update results
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
Published: 2022-07-28 (Crawled : 21:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 0.45%
H: 4.8%
C: 4.8%
report update results
Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
Published: 2022-07-12 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 2.63%
H: 1.75%
C: -1.29%
expansion patent
Viveve to Participate in H.C. Wainwright Global Investment Conference
Published: 2022-05-17 (Crawled : 21:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: -3.78%
H: 11.14%
C: 9.2%
conference
Viveve CEO Scott Durbin Named Among Top 50 Healthcare Technology Leaders of 2022 by Healthcare Technology Report
Published: 2022-05-17 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 0.0%
H: 6.41%
C: 1.28%
ceo report technology
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-05-12 (Crawled : 21:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 0.51%
H: 4.8%
C: 3.48%
results
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
Published: 2022-04-28 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 4.49%
H: 0.86%
C: -2.04%
report results
Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-17 (Crawled : 21:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 3.97%
H: 3.96%
C: 3.96%
financial results report results
Viveve to Report Full Year 2021 Financial Results and Provide Corporate Update on March 17, 2022
Published: 2022-03-03 (Crawled : 13:30) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: -0.02%
H: 3.19%
C: -1.06%
financial results report results
Healthcare Technology Report Names Viveve Regulatory Executive Among Top 25 Women Leaders in Medical Devices
Published: 2022-01-13 (Crawled : 13:30) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.56%
health ces thc device technology women
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.